Table 1.
| Crohn’s Disease Patients (n=4) | UC Patients (n=9) | |
|---|---|---|
| Sex | 3 Male | 9 Male |
| Race | 4 Caucasian | 9 Caucasian |
| Age at Diagnosis (Years) | 12 (Range: 8-16) | 19 (Range: 10-25) |
| Age at Enrollment (Years) | 20 (Range: 18-23) | 24 (Range: 14-29) |
| Disease Index | ||
| Mild | 4 | 3 |
| Mild/Moderate | 0 | 3 |
| Moderate | 0 | 3 |
| Concomitant Medications * | ||
| Amino-salicylates | 1 | 4 |
| Immunomodulators (6MP, MTX) | 0 | 2 |
| Anti-TNF Biologics | 3 | 4 |
| Other Biologics | 2 | 0 |
| Corticosteroids | 1 | 5 |
| Antibiotics | 2 | 2 |
| Baseline Fecal Calprotectin (μg/g) ** | 1440 (Range: 1430-1450) | 2190 (Range: 5-5730) |
| Normal: <50 | N=2 | |
| Baseline CRP (mg/L) ** | 2.45 (Range: 0.3-5.2) | 1.9 (Range: 0.3-14.7) |
| Normal: 0-4.9 mg/L | ||
| Baseline ESR (mm/hr) ** | 14.5 (Range: 2-41) | 12 (Range: 2-79) |
| Normal: 0-32 mm/hr | ||
| Prior IBD-Related Hospitalization | ||
| Yes | 2 | 6 |
| No | 0 | 1 |
| Unknown | 2 | 2 |
| Arm Assigned | ||
| Treatment | 2 | 6 |
| Placebo | 2 | 3 |
total > n because patients may be on multiple medications
Median values shown